Abstract
Sepsis-associated encephalopathy (SAE) is a clinical syndrome of brain dysfunction secondary to sepsis, which is characterized by long-term neurocognitive deficits such as memory, attention, and executive dysfunction. However, the mechanisms underlying SAE remain unclear. By using transcriptome sequencing approach, we showed that hippocampal S100A9 was significantly increased in sepsis induced by cecal ligation and puncture (CLP) or lipopolysaccharide (LPS) challenge. Thus, we used S100A9 inhibitor Paquinimod to study the role of S100A9 in cognitive impairments in CLP-induced and LPS-induced mice models of SAE. Sepsis survivor mice underwent behavioral tests or the hippocampal tissues subjected to Western blotting, real-time quantitative PCR, and immunohistochemistry. Our results showed that CLP-induced and LPS-induced memory impairments were accompanied with increased expressions of hippocampal microglia Iba1 and CD86 (M1 markers), but reduced expression of Arg1 (M2 marker). Notably, S100A9 inhibition significantly improved the survival rate and learning and memory impairments in sepsis survivors, with a shift from M1 to M2 phenotype. Taken together, our study suggests that S100A9 upregulation might contribute to learning and memory impairments by promoting microglia M1 polarization in sepsis survivors, whereas S100A9 inhibition might provide a potential therapeutic target for SAE.
Similar content being viewed by others
References
Gofton, T.E., and G.B. Young. 2012. Sepsis-associated encephalopathy. Nature Reviews. Neurology 8: 557–566.
Iwashyna, T.J., E.W. Ely, D.M. Smith, and K.M. Langa. 2010. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304: 1787–1794.
Widmann, Catherine N., and Michael T. Heneka. 2014. Long-term cerebral consequences of sepsis. The Lancet Neurology 13: 630–636.
Helbing, D.L., L. Bohm, and O.W. Witte. 2018. Sepsis-associated encephalopathy. CMAJ 190: E1083.
Ji, M.H., L.L. Qiu, H. Tang, L.S. Ju, X.R. Sun, H. Zhang, M. Jia, Z.Y. Zuo, J.C. Shen, and J.J. Yang. 2015. Sepsis-induced selective parvalbumin interneuron phenotype loss and cognitive impairments may be mediated by NADPH oxidase 2 activation in mice. Journal of Neuroinflammation 12: 182.
Michels, M., A.S. Vieira, F. Vuolo, H.G. Zapelini, B. Mendonca, F. Mina, D. Dominguini, et al. 2015. The role of microglia activation in the development of sepsis-induced long-term cognitive impairment. Brain, Behavior, and Immunity 43: 54–59.
Nacken, W., J. Roth, C. Sorg, and C. Kerkhoff. 2003. S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microscopy Research and Technique 60: 569–580.
Vogl, T., A.L. Gharibyan, and L.A. Morozova-Roche. 2012. Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes. International Journal of Molecular Sciences 13: 2893–2917.
Vogl, T., M. Eisenblatter, T. Voller, S. Zenker, S. Hermann, P. van Lent, A. Faust, et al. 2014. Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity. Nature Communications 5: 4593.
Chen, B., A.L. Miller, M. Rebelatto, Y. Brewah, D.C. Rowe, L. Clarke, M. Czapiga, K. Rosenthal, T. Imamichi, Y. Chen, C.S. Chang, P.S. Chowdhury, B. Naiman, Y. Wang, D. Yang, A.A. Humbles, R. Herbst, and G.P. Sims. 2015. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo. PLoS One 10: e0115828.
Wang, S., R. Song, Z. Wang, Z. Jing, S. Wang, and J. Ma. 2018. S100A8/A9 in inflammation. Frontiers in Immunology 9: 1298.
Denstaedt, S.J., J.L. Spencer-Segal, M.W. Newstead, K. Laborc, A.P. Zhao, A. Hjelmaas, X. Zeng, H. Akil, T.J. Standiford, and B.H. Singer. 2018. S100A8/A9 drives neuroinflammatory priming and protects against anxiety-like behavior after sepsis. Journal of Immunology 200: 3188–3200.
Engel, S., H. Schluesener, M. Mittelbronn, K. Seid, D. Adjodah, H.D. Wehner, and R. Meyermann. 2000. Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathologica 100: 313–322.
Horvath, I., I.A. Iashchishyn, R.A. Moskalenko, C. Wang, Warmlander Skts, C. Wallin, A. Graslund, G.G. Kovacs, and L.A. Morozova-Roche. 2018. Co-aggregation of pro-inflammatory S100A9 with alpha-synuclein in Parkinson's disease: ex vivo and in vitro studies. Journal of Neuroinflammation 15: 172.
Shepherd, C.E., J. Goyette, V. Utter, F. Rahimi, Z. Yang, C.L. Geczy, and G.M. Halliday. 2006. Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease. Neurobiology of Aging 27: 1554–1563.
Wang, C., A.G. Klechikov, A.L. Gharibyan, S.K. Wärmländer, J. Jarvet, L. Zhao, X. Jia, et al. 2014. The role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascade. Acta Neuropathologica 127: 507–522.
Dubois, C., D. Marce, V. Faivre, A.C. Lukaszewicz, C. Junot, F. Fenaille, S. Simon, F. Becher, N. Morel, and D. Payen. 2019. High plasma level of S100A8/S100A9 and S100A12 at admission indicates a higher risk of death in septic shock patients. Scientific Reports 9: 15660.
Wu, M., L. Xu, Y. Wang, N. Zhou, F. Zhen, Y. Zhang, X. Qu, H. Fan, S. Liu, Y. Chen, and R. Yao. 2018. S100A8/A9 induces microglia activation and promotes the apoptosis of oligodendrocyte precursor cells by activating the NF-kappaB signaling pathway. Brain Research Bulletin 143: 234–245.
Kummer, M.P., T. Vogl, D. Axt, A. Griep, A. Vieira-Saecker, F. Jessen, E. Gelpi, J. Roth, and M.T. Heneka. 2012. Mrp14 deficiency ameliorates amyloid beta burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing. The Journal of Neuroscience 32: 17824–17829.
Gruden, M.A., T.V. Davydova, V.S. Kudrin, C. Wang, V.B. Narkevich, L.A. Morozova-Roche, and R.D.E. Sewell. 2018. S100A9 protein aggregates boost hippocampal glutamate modifying monoaminergic neurochemistry: A glutamate antibody sensitive outcome on Alzheimer-like memory decline. ACS Chemical Neuroscience 9: 568–577.
Rittirsch, D., M.S. Huber-Lang, M.A. Flierl, and P.A. Ward. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nature Protocols 4: 31–36.
Liu, W., W. Guo, Y. Zhu, S. Peng, W. Zheng, C. Zhang, F. Shao, Y. Zhu, N. Hang, L. Kong, X. Meng, Q. Xu, and Y. Sun. 2018. Targeting peroxiredoxin 1 by a curcumin analogue, AI-44, inhibits NLRP3 inflammasome activation and attenuates lipopolysaccharide-induced sepsis in mice. Journal of Immunology 201: 2403–2413.
Leger, M., A. Quiedeville, V. Bouet, B. Haelewyn, M. Boulouard, P. Schumann-Bard, and T. Freret. 2013. Object recognition test in mice. Nature Protocols 8: 2531–2537.
Li, R., Y. Li, X. Fang, H. Yang, J. Wang, K. Kristiansen, and J. Wang. 2009. SNP detection for massively parallel whole-genome resequencing. Genome Research 19: 1124–1132.
Wang, J., C.G. Mullighan, J. Easton, S. Roberts, S.L. Heatley, J. Ma, M.C. Rusch, K. Chen, C.C. Harris, L. Ding, L. Holmfeldt, D. Payne-Turner, X. Fan, L. Wei, D. Zhao, J.C. Obenauer, C. Naeve, E.R. Mardis, R.K. Wilson, J.R. Downing, and J. Zhang. 2011. CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nature Methods 8: 652–654.
Li, H., B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, R. Durbin, and Subgroup Genome Project Data Processing. 2009. The sequence alignment/map format and SAMtools. Bioinformatics 25: 2078–2079.
Chiang, D.Y., G. Getz, D.B. Jaffe, M.J. O'Kelly, X. Zhao, S.L. Carter, C. Russ, C. Nusbaum, M. Meyerson, and E.S. Lander. 2009. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nature Methods 6: 99–103.
Yang, H., and K. Wang. 2015. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nature Protocols 10: 1556–1566.
Mina, F., C.M. Comim, D. Dominguini, O.J. Cassol Jr., D.M. Dall Igna, G.K. Ferreira, M.C. Silva, et al. 2014. Il1-beta involvement in cognitive impairment after sepsis. Molecular Neurobiology 49: 1069–1076.
Bi, W., X. Lan, J. Zhang, S. Xiao, X. Cheng, H. Wang, D. Lu, and L. Zhu. 2019. USP8 ameliorates cognitive and motor impairments via microglial inhibition in a mouse model of sepsis-associated encephalopathy. Brain Research 1719: 40–48.
Xu, X.E., L. Liu, Y.C. Wang, C.T. Wang, Q. Zheng, Q.X. Liu, Z.F. Li, X.J. Bai, and X.H. Liu. 2019. Caspase-1 inhibitor exerts brain-protective effects against sepsis-associated encephalopathy and cognitive impairments in a mouse model of sepsis. Brain, Behavior, and Immunity 80: 859–870.
Buras, J.A., B. Holzmann, and M. Sitkovsky. 2005. Animal models of sepsis: setting the stage. Nature Reviews. Drug Discovery 4: 854–865.
Ometto, F., L. Friso, D. Astorri, C. Botsios, B. Raffeiner, L. Punzi, and A. Doria. 2017. Calprotectin in rheumatic diseases. Experimental Biology and Medicine (Maywood, N.J.) 242: 859–873.
Chiu, C.W., H.M. Chen, T.T. Wu, Y.C. Shih, K.K. Huang, Y.F. Tsai, Y.L. Hsu, and S.F. Chen. 2015. Differential proteomics of monosodium urate crystals-induced inflammatory response in dissected murine air pouch membranes by iTRAQ technology. Proteomics 15: 3338–3348.
Cesaro, A., N. Anceriz, A. Plante, N. Page, M.R. Tardif, and P.A. Tessier. 2012. An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis. PLoS One 7: e45478.
Fu, Q., J. Wu, X.Y. Zhou, M.H. Ji, Q.H. Mao, Q. Li, M.M. Zong, Z.Q. Zhou, and J.J. Yang. 2019. NLRP3/caspase-1 pathway-induced pyroptosis mediated cognitive deficits in a mouse model of sepsis-associated encephalopathy. Inflammation 42: 306–318.
Imamura, Y., H. Wang, N. Matsumoto, T. Muroya, J. Shimazaki, H. Ogura, and T. Shimazu. 2011. Interleukin-1beta causes long-term potentiation deficiency in a mouse model of septic encephalopathy. Neuroscience 187: 63–69.
Lorey, M.B., K. Rossi, K.K. Eklund, T.A. Nyman, and S. Matikainen. 2017. Global characterization of protein secretion from human macrophages following non-canonical caspase-4_5 inflammasome activation. Molecular & Cellular Proteomics 16: S187–S199.
Singer, B.H., M.W. Newstead, X. Zeng, C.L. Cooke, R.C. Thompson, K. Singer, R. Ghantasala, J.M. Parent, G.G. Murphy, T.J. Iwashyna, and T.J. Standiford. 2016. Cecal ligation and puncture results in long-term central nervous system myeloid inflammation. PLoS One 11: e0149136.
Hirbec, H.E., H.N. Noristani, and F.E. Perrin. 2017. Microglia responses in acute and chronic neurological diseases: what microglia-specific transcriptomic studies taught (and did not teach) us. Frontiers in Aging Neuroscience 9: 227.
Bah, I., A. Kumbhare, L. Nguyen, C.E. McCall, and M. El Gazzar. 2018. IL-10 induces an immune repressor pathway in sepsis by promoting S100A9 nuclear localization and MDSC development. Cellular Immunology 332: 32–38.
Szollosi, D., N. Hegedus, D.S. Veres, I. Futo, I. Horvath, N. Kovacs, B. Martinecz, et al. 2018. Evaluation of brain nuclear medicine imaging tracers in a murine model of sepsis-associated encephalopathy. Molecular Imaging and Biology 20: 952–962.
Lemstra, A.W., J.C. Groen in’t Woud, J.J. Hoozemans, E.S. van Haastert, A.J. Rozemuller, P. Eikelenboom, and W.A. van Gool. 2007. Microglia activation in sepsis: a case-control study. Journal of Neuroinflammation 4: 4.
Pan, S., Y. Wu, L. Pei, S. Li, L. Song, H. Xia, Y. Wang, Y. Yu, X. Yang, H. Shu, J. Zhang, S. Yuan, and Y. Shang. 2018. BML-111 reduces neuroinflammation and cognitive impairment in mice with sepsis via the SIRT1/NF-kappaB signaling pathway. Frontiers in Cellular Neuroscience 12: 267.
Zhang, S., X. Wang, S. Ai, W. Ouyang, Y. Le, and J. Tong. 2017. Sepsis-induced selective loss of NMDA receptors modulates hippocampal neuropathology in surviving septic mice. PLoS One 12: e0188273.
Moraes, C.A., G. Santos, T.C. de Sampaio e Spohr, J.C. D’Avila, F.R. Lima, C.F. Benjamim, F.A. Bozza, and F.C. Gomes. 2015. Activated microglia-induced deficits in excitatory synapses through IL-1beta_ implications for cognitive impairment in sepsis. Molecular Neurobiology 52: 653–663.
Zrzavy, T., R. Hoftberger, T. Berger, H. Rauschka, O. Butovsky, H. Weiner, and H. Lassmann. 2019. Pro-inflammatory activation of microglia in the brain of patients with sepsis. Neuropathology and Applied Neurobiology 45: 278–290.
Semmler, A., T. Okulla, M. Sastre, L. Dumitrescu-Ozimek, and M.T. Heneka. 2005. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. Journal of Chemical Neuroanatomy 30: 144–157.
Zhang, L.N., X.H. Wang, L. Wu, L. Huang, C.G. Zhao, Q.Y. Peng, and Y.H. Ai. 2016. Diagnostic and predictive levels of calcium-binding protein A8 and tumor necrosis factor receptor-associated factor 6 in sepsis-associated encephalopathy: a prospective observational study. Chinese Medical Journal 129: 1674–1681.
Li, P., X.R. Chen, F. Xu, C. Liu, C. Li, H. Liu, H. Wang, W. Sun, Y.H. Sheng, and X.Q. Kong. 2018. Alamandine attenuates sepsis-associated cardiac dysfunction via inhibiting MAPKs signaling pathways. Life Sciences 206: 106–116.
Funding
This work was supported by Natural Science Foundation of Fujian Province (No. 2017J01246) and Youth Research Project of Health Commission of Fujian Province (Nos. 2016-1-28 and 2018-1-31).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Liao, YL., Zhou, XY., Ji, MH. et al. S100A9 Upregulation Contributes to Learning and Memory Impairments by Promoting Microglia M1 Polarization in Sepsis Survivor Mice. Inflammation 44, 307–320 (2021). https://doi.org/10.1007/s10753-020-01334-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-020-01334-6